Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ISRCTN16144716) titled 'Innovative treatments for the recovery implementation program' on Dec. 16, 2025.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Blinded (masking used)
Control: Uncontrolled
Assignment: Sequential
Purpose: Health services research
Primary Sponsor: Quality Enhancement Research Initiative
Condition:
Implementation of evidence-based treatments for posttraumatic stress disorder and treatment-resistant depression.
Mental and Behavioural Disorders
Intervention:
These studies are part of a multicenter step-wedged hybrid type-2 implementation effectiveness mixed-methods qu...